- Ana Sayfa
- Uygulama Analitiği
- PatienTrials
- PatienTrials Vs. VirTrial Participant
PatienTrials vs VirTrial Participant Kullanım & İstatistikleri
PatienTrials helps pharma companies and clinicians run global clinical trials virtually, more efficiently in a closed community setting over HIPAA & GDPR compliant collaboration platform. PatienTrials aims to improve patient adherence by empowering participants with information on the progress of treatment at their fingertips in a community setting, that promotes self-care. PatienTrials captures high-quality patient generated data through solutions based on instant messaging, HealthKit, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring clinical trials on to a HIPAA & GDPR compliant instant messaging platform.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
VirTrial provides convenient access to clinical trials for study participants around the world.
The VirTrial Patient application connects study participants to the research site staff for virtual telemedicine visits within a study protocol. The VirTrial app provides a virtual exam room for study participants to see the study staff and physician without the inconvenience of travel to the study site.
VirTrial complies with all local, national and global compliance and security requirements
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
PatienTrials ile VirTrial Participant için sıralama karşılaştırması
Son 28 gündeki PatienTrials sıralama trendini VirTrial Participantile karşılaştırın
Rank
Mevcut veri yok
PatienTrials vs. VirTrial Participant ülke karşılaştırmasına göre sıralama
Son 28 gündeki PatienTrials sıralama trendini VirTrial Participantile karşılaştırın
Gösterilecek bilgi yok
Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın
PatienTrials VS.
VirTrial Participant
Aralık 15, 2024